Table 4 Comparison of side effects of therapies between groups
variable | TB treatment n (%) | Lung cancer n (%) | P value |
|---|---|---|---|
Leukocyte deficiency | 0.887 | ||
Nothing | 13 (41.9) | 26 (51.0) | |
Grade 1 | 7 (22.6) | 10 (19.6) | |
Grade 2 | 8 (25.8) | 11 (21.6) | |
Grade 3 | 3 (9.7) | 4 (7.8) | |
Thrombocytopenia | 0.508 | ||
Nothing | 19 (61.3) | 37 (72.5) | |
Grade 1 | 6 (19.4) | 5 (9.8) | |
Grade 2 | 4 (12.9) | 5 (9.8) | |
Grade 3 | 2 (6.5) | 2 (3.9) | |
Grade 4 | 0 (0) | 2 (3.9) | |
Renal toxic effects | 0.236 | ||
Nothing | 15 (48.4) | 27 (52.9) | |
Grade 1 | 14 (45.2) | 24 (47.1) | |
Grade 2 | 2 (6.5) | 0 (0) | |
Liver toxicity | 0.173 | ||
Nothing | 12 (38.7) | 24 (47.1) | |
Grade 1 | 12 (38.7) | 23 (45.1) | |
Grade 2 | 5 (16.1) | 4 (7.8) | |
Grade 3 | 2 (6.5) | 0 (0) | |
Gastrointestinal toxicity | 0.067 | ||
Nothing | 15 (48.4) | 32 (62.8) | |
Grade 1 | 9 (29.0) | 13 (25.5) | |
Grade 2 | 7 (22.6) | 5 (9.8) | |
Grade 3 | 0 (0) | 1 (2.0) | |
Cardiac toxic effects | 6 (19.4) | 7 (13.7) | 0.499 |
Neurotoxicity | 0 (0) | 0 (0) | 1 |